Glucose metabolism and catecholamines
- 1 September 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 35 (Suppl), S508-S518
- https://doi.org/10.1097/01.ccm.0000278047.06965.20
Abstract
Until now, catecholamines were the drugs of choice to treat hypotension during shock states. Catecholamines, however, also have marked metabolic effects, particularly on glucose metabolism, and the degree of this metabolic response is directly related to the β2-adrenoceptor activity of the individual compound used. Under physiologic conditions, infusing catecholamine is associated with enhanced rates of aerobic glycolysis (resulting in adenosine triphosphate production), glucose release (both from glycogenolysis and gluconeogenesis), and inhibition of insulin-mediated glycogenesis. Consequently, hyperglycemia and hyperlactatemia are the hallmarks of this metabolic response. Under pathophysiologic conditions, the metabolic effects of cate-cholamines are less predictable because of changes in receptor affinity and density and in drug kinetics and the metabolic capacity of the major gluconeogenic organs, both resulting from the disease per se and the ongoing treatment. It is also well-established that shock states are characterized by a hypermetabolic condition with insulin resistance and increased oxygen demands, which coincide with both compromised tissue microcirculatory perfusion and mitochondrial dysfunction. This, in turn, causes impaired glucose utilization and may lead to inadequate glucose supply and, ultimately, metabolic failure. Based on the landmark studies on intensive insulin use, a crucial role is currently attributed to glucose homeostasis. This article reviews the effects of the various catecholamines on glucose utilization, both under physiologic conditions, as well as during shock states. Because, to date (to our knowledge), no patient data are available, results from relevant animal experiments are discussed. In addition, potential strategies are outlined to influence the catecholamine-induced effects on glucose homeostasis.Keywords
This publication has 103 references indexed in Scilit:
- High-dose vasopressin is not superior to norepinephrine in septic shock*Critical Care Medicine, 2003
- Metabolic Effects of Norepinephrine and Dobutamine in Healthy VolunteersShock, 2002
- Role of skeletal muscle Na+–K+ ATPase activity in increased lactate production in sub–acute sepsisLife Sciences, 2002
- Superoxide activates mitochondrial uncoupling proteinsNature, 2002
- Metabolic effects of vasoactive agentsCurrent Opinion In Anesthesiology, 2001
- Determination of13CO2/12CO2Ratio by IRMS and NDIRSIsotopes in Environmental and Health Studies, 1998
- Alterations in carbohydrate metabolism during stress: A review of the literatureAmerican Journal Of Medicine, 1995
- Impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shockCritical Care Medicine, 1993
- Effect of Severe Burn Injury on Substrate Cycling by Glucose and Fatty AcidsNew England Journal of Medicine, 1987
- Influence of free fatty acids on myocardial oxygen consumption and ischemic injuryThe American Journal of Cardiology, 1981